W.L. Gore & Associates wins CE Mark approval in the European Union for its vascular prosthesis.

W.L. Gore & Associates  touted CE Mark approval in the European Union for its Gore Hybrid Vascular Graft.

The device, which won FDA clearance in 2010, is indicated for use as replacement or bypass of diseased blood vessels while addressing common causes of graft failure.

The graft is a vascular prosthesis designed to expand treatment options for blood outflow by working in the maximum number of sites available.